BB Biotech AG (XSWX:BION) 3-Year Book Growth Rate : -15.50% (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is BB Biotech AG 3-Year Book Growth Rate?

BB Biotech AG's Book Value per Share for the quarter that ended in Dec. 2023 was CHF42.36.

During the past 12 months, BB Biotech AG's average Book Value per Share Growth Rate was -13.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was -15.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was -5.20% per year. During the past 10 years, the average Book Value per Share Growth Rate was 0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of BB Biotech AG was 80.50% per year. The lowest was -15.50% per year. And the median was 3.65% per year.

Competitive Comparison of BB Biotech AG's 3-Year Book Growth Rate

For the Biotechnology subindustry, BB Biotech AG's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BB Biotech AG's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's 3-Year Book Growth Rate falls into.

BB Biotech AG 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

BB Biotech AG (XSWX:BION) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

BB Biotech AG 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG (XSWX:BION) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (XSWX:BION) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

BIONz:UK BBZA:Germany

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

Executives

Prof. Dr. Mads Krogsgaard Thomsen

Supervisory Board

BB Biotech AG (XSWX:BION) Headlines

No Headlines